tiprankstipranks
Advertisement
Advertisement

KSPHF Stock Latest News

Kissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
Company AnnouncementsKissei Pharmaceutical Grants Restricted Stock to Board Members and Officers
3d ago
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
PremiumCompany Announcements
Kissei Pharmaceutical Sets Share Buyback Framework but Executes No Purchases in May
23d ago
Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib
PremiumCompany Announcements
Kissei Files Japan NDA for IDH1-Targeting AML Drug Olutasidenib
30d ago
Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases
PremiumCompany Announcements
Kissei Tightens Safety Warnings on TAVNEOS After Serious Liver Risk Cases
1M ago
Kissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns
PremiumCompany Announcements
Kissei Restricts TAVNEOS Use in Japan After Global Safety and Data Concerns
1M ago
Kissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify
PremiumCompany AnnouncementsKissei Pharmaceutical Posts Record Sales as R&D Investment and Overseas Growth Intensify
1M ago
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
Premium
Company Announcements
Kissei Pharmaceutical Launches ¥6 Billion Share Buyback and Cancellation Plan
2M ago
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
Premium
Company Announcements
Kissei Pharmaceutical Details FY2026 Results and R&D Pipeline in Supplementary Report
2M ago
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
PremiumCompany Announcements
Kissei Pharmaceutical Swings to Operating Loss but Lifts Payouts and Eyes Profit Recovery
2M ago
KSPHF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-Earnings
KSPHF Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2M ago
Kissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
PremiumCompany Announcements
Kissei sublicenses AML drug olutasidenib to Orient EuroPharma in Taiwan
2M ago
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
PremiumCompany Announcements
Kissei Pharmaceutical Names Research Chief Keiji Miyazawa as New President and COO
2M ago
Kissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
PremiumCompany AnnouncementsKissei Launches Yselty in Japan, Expanding Global Uterine Fibroid Treatment Portfolio
3M ago
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
Premium
Company Announcements
Kissei Pharmaceutical to Allocate ¥2.4 Billion in Treasury Shares to Employee Shareholding Plan
4M ago
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
Premium
Company Announcements
Kissei Pharmaceutical Marks 80th Anniversary With Special Dividends and Higher Payout
5M ago
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
PremiumCompany Announcements
Kissei Pharmaceutical Releases Supplementary Materials on Nine-Month FY2025 Results and R&D Pipeline
5M ago
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
PremiumCompany Announcements
Kissei Pharmaceutical Lifts Sales and Earnings, Boosts Payouts Despite Operating Loss
5M ago
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
PremiumPre-Earnings
Kissei Pharmaceutical Co (KSPHF) Q3 Earnings Cheat Sheet
5M ago
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
PremiumCompany Announcements
Kissei Wins Japan Approval for Oral GnRH Antagonist Yselty for Uterine Fibroids
6M ago
Kissei Pharmaceutical initiated with a Neutral at UBS
PremiumThe FlyKissei Pharmaceutical initiated with a Neutral at UBS
6M ago
Kissei Pharmaceutical Adjusts Dividend Payment Date
Premium
Company Announcements
Kissei Pharmaceutical Adjusts Dividend Payment Date
7M ago
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
Premium
Company Announcements
Kissei Pharmaceutical Co Reports Growth Amid Increased R&D Investment
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >